In April 2015, the affiliation of the Department of Experimental Therapeutics was changed from the National Cancer Center (NCC) – the Exploratory Oncology Research & Clinical Trial Center (EPOC) to the NCC-Hospital. The goal of our Department is to perform initial clinical evaluation of promising new anti-cancer compounds emerging from the laboratory in phase I trials. Currently 11 doctors are working as a multidisciplinary team for various medical oncology fields including thoracic oncology, gastrointestinal oncology, hepatobiliary and pancreatic oncology and breast and medical oncology.